chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itching; breaking out in red rash; This is a spontaneous report from a contactable consumer reported for herself. A 54-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 12Apr2021 (Batch/Lot Number: ER8732) as single dose for covid-19 immunisation. Patient received the first dose on unknown date. Medical history included gastrointestinal disorder, knee arthroplasty, facial paralysis, hypersensitivity, migraine. Concomitant medications included dicycloverine hydrochloride (BENTYL); duloxetine hydrochloride (CYMBALTA); pregabalin (LYRICA); sertraline hydrochloride (ZOLOFT); tamsulosin; tizanidine. The patient experienced breaking out and itching, breaking out in red rash on 12Apr2021. Outcome of events was not recovered.   No follow-up attempts are needed. No further information is expected.
Initially after receiving the vaccine, patient felt well. Within 48 hours, patient felt like her brain was swelling and subsequent pressure against both ears was unbearable and severe fatigue. With no previous history of headaches or migraines, patient states severe headaches were present. Loud, high-pitched agonizing sound in ears/brain which would not cease including disrupting sleep. No previous history of tinnitus. Ten months later, no relief from the tinnitus.   On 04/20/2022, patient went to the emergency room at Medical Center; only to be dismissed by Dr. who refused to report any side-effects or recognize complaints of tinnitus and pressure in ears & only focused on fatigue.   He stated no one has given him instructions to report side effect. Patient complained to the hospital administer to report this incident. The administer said he would look into this and have corrections made. He stated to the patient the doctors must report vaccine side effects.   Patient made appointment to see an ENT but the earliest appointment was on 05/17/2021. Patient complained about fullness in the ears and tinnitus since the receiving of the J&J vaccine. Dr. said patient was his first to complain about the J&J's tinnitus effect whereas the other patients with the same side effects had taken the Moderna vaccine. However, all mention of the J&J vaccine has been omitted from his medical notes. Even the patient's vaccine list fails to include the J&J vaccine.  To date - January 23, 2022: No relief from the tinnitus.
PT recvd DTP/HBOC @ 1600 & about 1930 mom felt pt seemed limp, cold, & clammy, & pale w/poor appetite; no fever; Mom called MD & was advised to take pt to ER; pt evaluated & found nl; fever 101 R in ER;
Pleuritic L sided chest pain onset about 2 hours after vaccination, along with chills, myalgias and fever to 104. Fever and chills resolved overnight, chest pain persisted for 3 days.
He got his vaccine, didn't have any problems for about 3 days.  Then he went to bed, and got up around 4:00 AM, and had to use the restroom and when he went to get out of bed he fell on the floor.  He had no feeling from the waist down.  His daughter is a nurse and she cam in and they called an ambulance and he went to Hospital.  They gave him some IV's, put him in bed, and around 2:00 PM he was fine, and could walk.  They put him in the hospital.  He also received the antibody infusion after he was discharged from the hospital, and he has done well since.   The doctor said that it might have affected his brain a little bit, and had been put on a vitamin for that.  He seems to be getting better, and has had some memory loss since the vaccine.  His daughter looked to find something to help his memory, and taking Metafolbic plus Cerefolin for 3 months and has an appointment to be seen then to see if it worked.    He did get his booster vaccine, Moderna, and he did not have any problems with that.
7/24 Raised area, warm, tender to touch at site of Tdap. Treated with BACTRIM -> 7/29, site improved (injection 7/23, site tender 7/24, Saturday 7/25 bump).
Suspect COVID breakthrough case  Presents after a Tylenol overdose- incidental COVID finding (asymptomatic)
Information has been received from a 66 year old male pharmacist with arthritis and a narcotic hypersensitivity who on 23-JUL-2007 was vaccinated in the left deltoid with a dose of PNEUMOVAX.  The patient received an intraarticular injection of methylprednisolone in the right shoulder several hours prior to the administration of PNEUMOVAX.  Concomitant therapy included CELEBREX, vitamin E, and an unspecified multivitamin.  On 24-JUL-2007 the patient developed arthralgia, redness, warmth, and a firm nodule at the injection site.  The pharmacist stated, "I can hardly move around because of the joint pain".  The patient self-treated with KEFLEX 1000-1500 mg daily for 5 days.  On approximately 25-JUL-2007 the patient recovered from the injection site reaction, but the arthralgia persisted.  The patient had an appointment scheduled on 16-AUG-2007 with his physician to evaluate the arthralgia.  The pharmacist considered arthralgia to be a disabling event.  Additional information has been requested.
This spontaneous report as received from a Registered Nurse (R.N.) refers to a patient of unknown age. On 11-APR-2016 the patient was vaccinated with improperly stored ROTATEQ (lot # L026741, Exp: 18-MAY-2017) orally and RECOMBIVAX HB (lot # L044707, Exp: 16-OCT-2018). Both vaccines were stored under 52.5 degrees Fahrenheit for 1 hour 15 minutes. There was no previous temperature excursion. It was called because of a data logger. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to her 4.5 year old grandson. The patient's concurrent conditions, medical history, drug allergies/reactions and concomitant medications, if any, were not reported. On an unknown date, the patient was vaccinated with PROQUAD, intramuscular rather than subcutaneous (dose number, dosage, frequency, anatomical site of vaccination, lot number and expiration date were not reported) for prophylaxis. Additionally, no adverse events were reported.
Lethargy, nausea, muscle spasm, continual headaches, dehydration, felt faint at time of injection, fever, swollen glands, leg pain, aching muscles, swollen glands armpit and face, dizziness. Had a headache since Jan 4 - 2017. Now easing up a bit. Recovering - easing up still headache.
Muscle soreness at the injection site, chills, nausea, headache, fever, teeth hurt, ache in left lung.  All symptoms presented within 8 hours and most lasted about 48 hours......slight fever still remains 2+ days later.
very dizzy starting 05/19/2021 upon awakening almost one week since covid vaccine; pt switched his clonidine paltch to a new patch and put it on the same arm that received the vaccine; over the area where received his shot and within 2 hrs began to feel very sleepy and very dizzy ; went to dr yest and bp 82/58; dad to provide more info so that VAER can be done it was a new box of patches ; looked same as always ; took patch off 5/19 around 530 pm; seemed to wear off 30min later; and started to feel better and less dizzy ; and tic symptoms increased.  Needed to take 0.1mg tab at bedtime to sleep next day dizziness "barely there"   has been drinking approx 4 waterbottles per day and eating well
"Pt w/ allergy to bovine collagen (SOB) and Glucosamine-chondroitin (SOB).  PMH significant for HTN and anxiety.  Pt vaccinated @10:46.  At 11:20, post-vaccination, pt was brought to the triage area due to complaints of lightheadedness and slight HA. Pt stated that she has hx of anxiety and HTN.   V/S @1120AM - BP: 170/99, HR: 88   NP further assessed pt and instructed pt to take her Amlodipine med, as prescribed. Pt was offered and given fluids, placed on recliner chair. Continued to monitor.   V/S @1140AM - BP: 186/96, HR: 86   Per pt, she did not eat breakfast this morning before appt. Pt was given crackers. Per pt, had taken her prescribed Lisinopril med in the AM. Continued to monitor.   V/S @1200PM - BP: 152/92, HR: 82   Pt verbalized improvement to sx and denied experiencing any new/abnormal sxs. NP cleared pt to be released from clinic. ED precautions given. Pt left with daughter with stable gait, AxOx4.  Current medications: Lisinopril 10mg PO Daily Amlodipine 5mg PO Daily Unknown if additional medications"
For 2 days post injection, I only had injection site pain. Starting the third day, I have had itching in both arms and both legs. It is always present. I try hard not to scratch. Applying topical emollients has yielded minimal benefit. I have been reluctant so far to take Benadryl.
Extreme fatigue, body aches, joint pain, headache, pain at injection site, swelling at injection site, itching at injection site, loss of appetite, hot flashes   I've just used ibuprofen, ice and warm showers for pain.
On Thursday, Jan 21st, I woke up with the worst heart burn and I thought I'd have to throw up.  Nothing I have ever experienced before. Then I ended up with a rash/hives on my rear which spread to my lower back and my thighs - later getting one on my face near my left eye. It only started itching a few days after.  I started taking Benadryl for a couple nights.   I found out my coworkers all had similar side effects and we all had the vaccine on the same day.   No one had any side effects right after having the shot - except for feeling tired.
feeling faint and hot; feeling faint and hot; the patient began to experience lightheadedness; Systemic reaction (hypoglycemia, hypotension, generalized rash); Systemic reaction (hypoglycemia, hypotension, generalized rash); Systemic reaction (hypoglycemia, hypotension, generalized rash); This is a spontaneous report from a non-contactable other health care professional.   A 28-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6206 and expiry date was not provided), via an unspecified route of administration on 12Mar2021, as SINGLE DOSE for COVID-19 immunisation. Medical history and concomitants were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE). The reporter stated that, during her 15-minute waiting period after the injection, the patient began to experience light-headedness and feeling faint and hot. She denied difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, facial swelling, lip swelling and tongue swelling. The patient received water, snacks and ice packs as the treatment. On an unknown date in Mar2021 the patient had differential diagnosis systemic reaction (hypoglycemia, hypotension, generalized rash). The reporter stated that that the patient having improvement of symptoms after observation in medical bay for 40 mins. She was to be taken home by her father who was able to come in to pick her up. The reporter stated that the patent wheeled to front by this provider and able to stand and walk assistance to car and she was monitored symptoms at home and follow up with PCP as needed. Outcome of the events was recovering.  No follow-up attempts are possible. No further information available.; Sender's Comments: Considering the known safety profile of the drug and a plausible temporal association between the reported events and the suspect drug BNT162B2, a causal relationship cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Information has been received from a physician concerning an infant who on approximately 23-NOV-2011, was vaccinated with a dose of ROTATEQ, 2 ml, orally (lot number not reported). Concomitant therapy included PEDIARIX, PREVNAR and Hib conj vaccine (unspecified carrier). A day later, 2 months ago, on approximately 24-NOV-2011, the patient experienced vomiting, diarrhoea, low grade fever and was inconsolable. The parents were told by the doctor to take the infant to the emergency room. It was also reported that the patient sought medical attention by phone. At the time of the report the patient's outcome was unknown. Additional information has been requested.
PT RECEIVED ZOSTAVAX ON 2/23/09.  ON 2/24/09, PT REPORTED NUMBNESS AND "A WEIRD FEELING" ON THE LEFT SIDE OF HIS FACE AND NECK.  HIS PHYSICIAN ADVISED HIM TO GO TO THE EMERGENCY ROOM.  PER PT, MRI AT ER "DIDN'T SHOW ANYTHING, BUT MY DOCTOR SAYS I HAD A MINI-STROKE."  PER PT, PHYSICIAN DOES NOT BELIEVE EVENT IS RELATED TO VACCINATION, BUT "I JUST WANTED TO LET YOU KNOW."  PT REPORTED NO RESIDUAL EFFECTS ON 2/24 AFTER VISITING ER.
mom reported pt had rash on legs, arms & face-erythema multiforme no other adverse rxn;
Chills, shaking, fever, vomiting, headache, sore muscles and joints all over, very tired, - at time of reporting I am still having these symptoms.
Hospitalization: Ulcerative colitis flare, severe and now chronic abdominal pain, autonomic nervous system dysfunction,  Unintended weight loss, malnutrition, loss of appetite
Patient does not remember most of the adverse event. Patient's partner reports that patient started feeling a tingling sensation on his left arm about 10 minutes after vaccination. Partner also reports that patient was hallucinating and sending her confusing text messages during his 15 minute observation period. The patient did not report feeling any adverse symptoms at the checkout station after his 15 minute observation period and before leaving the vaccination clinic.    After patient returned home, his partner reports considerable swelling on his left arm, continued hallucinations and trying to dismiss her concerns. Subsequently, that same day, partner reports the patient had a severe migrane and began to lose feeling on his left arm and leg, at which point the patient also lost consciousness.  Also at this point, the partner calls 911.   After arrival of emergency personnel, the patient regains consciousness, but does not remember name and complains of continued pain on his arm. He is transported to hospital where he spends 3 nights and receives treatment and care for stroke symptoms.    Patient reports that he does not remember much of anything 1.5 days after vaccination.   After returning home from hospital, patient complains of memory lapses and begins seeing neurologist for minor seizures during his sleep.   Wife reports that patient now lashes out and easily loses temper due to the fact that his memory is foggy.
101 Fever, chills, dizziness, - started about 7:30 pm until 6:30 am next morning, headache extreme that night, ongoing constant dull throb, fatigue still ongoing
My husband tested positive; My husband tested positive; This is a spontaneous report received from a Pfizer sponsored program. This consumer reported for her husband (patient) that:  A male patient of unknown age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 06Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 for Covid-19 Immunisation. Reporters husband tested positive on 01Apr2021 at Hospital after testing negative the day before at another Hospital. He had his second vaccine shot on 06Mar2021. On 01Apr2021, the patient was tested positive at Hospital, after testing negative the day before (31Mar2021) at Hospital. Outcome of the events was unknown.  Information about batch no/lot no has been requested.
left side of face began to tingle and be numb; left side of face began to tingle and be numb; 2 episodes of rapid heartbeat; burning in arm; lips and tongue started swelling; tongue started swelling; severe headache; A spontaneous report was received from a consumer reporting on herself, a 67-year-old female who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced left side of face began to tingle and be numb/MedDRA PT: Hemiparesthesia, rapid heartbeat/MedDRA PT: tachycardia, burning in arm/MedDRA PT: vaccination site burning, lips started swelling/MedDRA PT: swelling of  lips, tongue started swelling/MedDRA PT: swelling of tongue, severe and headache/MedDRA PT: headache.  The patient's medical history included allergy to latex and reaction to oseltamivir phosphate (Tamiflu).Products known to have been used by the patient, within two weeks prior to the event, included losartan, potassium citrate, diltiazem, allopurinol, atorvastatin, famotidine and levocetirizine.   On 12 Feb 2021, the patient received the first of two planned doses of mRNA-1273 ([LOT# 015M20A]) intramuscularly in the left arm for prophylaxis of COVID-19 infection. Four minutes after the vaccination, the patient felt burning in her arm and the left side of her face began to tingle and feel numb. In addition, the patient's lips and tongue began to swell and she had 2 episodes of rapid heart rate. Within 20 minutes it started to resolved and then she developed a severe headache.  On 13 Feb 2021, the patient reported that all of the symptoms were back except the fast heartbeat. The patient called Urgent Care and was prescribed treatment with diphyendramine and famotidine.   On 14 Feb 2021, the patient went to the emergency room and received a steroid injection, "liquid to drink", and steroid medication for 5 days. She reported a history of a similar reaction to oseltamivir phosphate (Tamiflu).  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events of left side of face began to tingle and be numb, 2 episodes of rapid heartbeat, burning in arm, lips and tongue started swelling and severe headache (12 Feb 2021) were considered recovered/resolved. The outcome of events of left side of face began to tingle and be numb, burning in arm, lips and tongue started swelling and severe headache (13 Feb 2021) were considered unknown; Reporter's Comments: This case concerns a 67-year-old female, with latex and drug allergies, who had serious unexpected hemiparesthesia and hypoaesthesia, NS unexpected lip swelling, swollen tongue, tachycardia, and NS expected vaccination site pain, headache. Event onset 4 minutes after first dose of mRNA-1273. Treated with Benadryl and steroids. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
HYPOXIA 3/31/2023 CHF EXACERBATION, UNSPECIFIED HYPOXIA 3/31/2023 AORTIC VALVE REGURGITATION
Developed papular, raised lesions with linearity on (R) arm, chest, upper lags and chest c/o itching. Treated with OTC BENADRYL, CLARITIN and prednisone.
My COVID-19 infection symptoms started on 12/16/2022 in the morning. I had ear pain, difficulty swallowing, cough, chills and low grade. On Saturday I did a home test which was negative. On 12/16/2022 in the late afternoon I went to the urgent care and they Strep test which was negative. On 12/17/2022 I went back in the urgent care and they did COVID-19 test and Flu. I was positive for COVID-19. They prescribed me PAXLOVID for 5 days. They next day on 12/18/2022 I called again and they send albuterol and prednisone. I recovered within 2 weeks but I still have the lingering cough which is not going away. I even went to my doctor's office he prescribed TYLENOL with codeine but still it's not helping with the cough.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 70-year-old patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included rheumatoid arthritis. Concomitant products included Biologics (Medication Unknown). In March 2019, the patient received the 1st dose of SHINGRIX. On an unknown date, 10 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional case details were provided as follows: The age at vaccination was not reported. The patient received the dose of SHINGRIX and 10 days later came down with a severe case of shingles. The patient want to know that does this vaccine gave shingles. No contact details were provided for further follow up.
No adverse effects reported; Pharmacist reports one dose of MMR II - was administered to patient - via the intramuscular rather than the subcutaneous route; Information has been received from a registered pharmacist reporting on a patient of unknown age and gender. There was no information regarding the patient's concomitant medication, pertinent medical history, drug reactions or allergies.  On 08-AUG-2019, the patient received an unspecified dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human albumin (rHA) (M-M-R II) for prophylaxis, lot # R031681, expiration date 01-NOV-2020 which was administered via intramuscular instead of subcutaneously. No adverse effects were reported.
1st wk in JAN97 pt started having pain in rt ankle that moved to pain in knee;approx 2 days p/3rd dose ankle began to swell;has had extreme tiredness & gen body aches & pains that are transient;had chills & fever;DVT in rt calf 7FEB97;
Started having Raynaud's and I thought that was strange, kept on getting it and now it is spring and despite of warmer temperatures it is not gone. No work up or medical advice as I am a physician . Temporal relation to receiving the 3rd dose of COVID vaccination!
itching all over; bad time with allergies; couldn't sleep; asthma was worse; red on her arm; second shot a lot worse than the first; This is a spontaneous report received from a contactable consumer or other non hcp. A 81-years-old female patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EL9266; Expiration Date: 31May2021), via an unspecified route of administration on 21Feb2021 ,at the age of 81 years old,as Dose 2 single for covid-19 immunization. Medical history included diabetes mellitus, neoplasm malignant Verbatim: cancer twice, asthma, osteoporosis, cardiac disorder, dermatitis contact and blood cholesterol abnormal from an unknown date and unknown if ongoing. The patient experienced itching all over, bad time with allergies, couldn't sleep, asthma was worse, red on her arm, second shot a lot worse than the first. The patient underwent lab tests and procedures which included body height: she is 5 foot 4 or 5 foot 5, stating that she shrunk , investigation: she had some sort of virus for about 3 weeks on, weight: 150 lbs on .Caller stated that she was 150 pounds and gained to 170.The outcome of the event was unknown.The patient previously received her 1st dose of Pfizer covid19 vaccine on 30Jan2021,lot EL892, exp 31May2021.Caller stated that she was asked when she took her 1st shot and was having reaction she thought it was because heart doctor had put on different cholesterol medication and she thought that she was reacting to that a little bit but then it eased off in a couple days. Upon transfer to medical information hold queue caller asked will the shots be as effective if she has taken Benadryl.